Introduction
============

Pulmonary complications are common complications following cardiac surgery with cardiopulmonary bypass (CPB) and are often associated with significant morbidity and mortality [@B1]-[@B5]. To clarify which patients are more prone to developing postoperative pulmonary complications may help to take effective measures to prevent, eliminate or ease postoperative pulmonary complications. Previous studies [@B6], [@B7] have reported the concept that postoperative pulmonary complications resulted from a combination of risk factors, mainly due to the nature of the patient population. However, few reports have focused on evaluating the intra- and post-operative risk factors for postoperative pulmonary complications [@B8].

We hypothesized that besides the nature of the patient population, some intra- and post-operative parameters may be risk factors for postoperative pulmonary complications. This study reviewed 2056 adult patients undergoing cardiac surgery with CPB in the department of cardiovascular surgery of Tongji Hospital of Tongji University in Shanghai from January 2005 to December 2012 to evaluate pre-, intra-, and post-operative independent risk factors for postoperative pulmonary complications, in order to prevent, eliminate or ease postoperative pulmonary complications.

Materials and methods
=====================

Definition
----------

Postoperative pulmonary complications included postoperative pneumonia and postoperative respiratory failure [@B9]. Postoperative pneumonia was defined as a positive result in a sputum culture requiring anti-infective treatment, or chest X-ray diagnosis of pneumonia following cardiac surgery. Postoperative respiratory failure was defined as the duration of mechanical ventilation more than 48 hours or re-intubation following cardiac surgery. Hospital mortality was defined as death that occurred during the same hospitalization or within 30 days of operation [@B10].

Criteria for extubation included an alert and hemodynamically stable patient with no excessive bleeding, ability of the patient to breathe through a tracheal tube (T tube) for at least 30 minutes with a fraction of inspired oxygen of less than 0.40 and a respiratory rate less than 25 breaths/min, PaO~2~ greater than 70mmHg, a PaCO~2~ less than 40mmHg and a pH greater than 7.35, with no metabolic acidosis. Other criteria included a tidal volume of 6ml/kg, a peak negative inspiratory pressure of less than -20cmH~2~O and a mandatory chest radiograph before extubation to rule out pneumothorax, pleural effusion and atelectasis.

Clinical data
-------------

This study protocol was approved by the ethics committee of Tongji University and was consistent with the *Declaration of Helsinki*.

From January 2005 to December 2012, all adult patients undergoing cardiac surgery with CPB were investigated and retrospectively analyzed. Preoperative information included age, gender, body mass index, recent smoking (within 4 weeks of surgery), chronic obstructive pulmonary disease, hypertension, hypercholesterolemia, diabetes mellitus, cerebrovascular disease, chronic renal dysfunction (creatinine \>2.5mg/dL or requiring dialysis), recent myocardial infarction (evidence of myocardial infarction within the last 30 days before surgery), preoperative heart failure (New York Heart Association class III and IV), preoperative vasoactive drugs support, atrial fibrillation, prior heart operation, impaired left ventricular function (left ventricular ejection fraction \<35%), left ventricular end-diastolic diameter, long-term use of steroid hormone, PaO~2~, and preoperative hemoglobin level. Intraoperative variables included emergency operation, type of operation, and duration of CPB and aortic cross-clamping (ACC). Postoperative variables included peri-operative use of intra-aortic balloon pump (IABP), postoperative arrhythmia, acute myocardial infarction (new Q-wave infarction within 48 hours following surgery), acute kidney injury (absolute increase greater than 0.3 mg/dl or relative increase greater than 50% in the serum creatinine within 48h after surgery, or requiring dialysis), postoperative cerebral vascular accident (new permanent neurologic event), pleural effusion, sternal infection (bone-related; any drainage of purulent material from the sternotomy wound, and instability of the sternum), reoperation for bleeding (re-operation to control bleeding within 36h following initial surgery), anaemia (haematocrit less than 34%), and right or bilateral phrenic nerve injury[@B11]-[@B14]. Right phrenic nerve injury was considered present when the dome of the right hemidiaphragm was two or more intercostal spaces higher than the left as seen on a plain chest roentgenogram or when right phrenic nerve transection was noted intraoperatively [@B15]. In addition, postoperative pneumonia, postoperative respiratory failure, re-intubation and duration of mechanical ventilation were recorded.

The primary endpoint was the occurrence of postoperative pulmonary complications comprising postoperative pneumonia and postoperative respiratory failure. The secondary endpoint was a composite of mortality and major adverse cardiac and cerebral vascular events (myocardial infarction, stroke, renal failure) occurring during the same hospitalization or within 30 days of operation.

Anesthesia and cardiopulmonary bypass procedure
-----------------------------------------------

All patients underwent general anesthesia. Anesthesia was induced with midazolam (2-3mg), fentanyl (0.2mg), propofol (0.5-1.5mg/kg) and vecuronium, and was maintained with inhaled isoflurane and continuous infusion of propofol (2 to 5 mg/kg/h). 0.1-0.2mg fentanyl was intravenously administered before skin incision, sternotomy, aortic cannulation and initiation of cardiopulmonary bypass, respectively; and total amount of fentanyl was less than 15µg/kg during operation.

All operations were performed with a midline incision and CPB. CPB was instituted with a single two-stage right atrial cannulation or double vena cava cannulation and an ascending aorta perfusion cannulation or femoral aortic perfusion cannulation. Standard management included membrane oxygenators, arterial catheter filters, and non-pulsatile flow of 2.4L/min/m^2^, with a mean arterial blood pressure greater than 50mmHg. Patients were heparinized with 300 IU/kg to achieve an activated clotting time \>480s. Heparin was neutralized with 1mg protamine sulfate per 100 IU given. Cold-blood cardioplegia and epicardial ice shavings (protective pads for phrenic nerve were not used) were used during cardiac surgery. Cold-blood cardioplegia was accomplished with anterograde delivery through the aortic root or coronary artery orifices and retrograde delivery through the coronary sinus.

Statistical analysis
--------------------

Statistical analysis was performed using the SPSS13.0 statistical software package. All *p* values \<0.05 were considered to be statistically significant. Univariate analysis, using the unpaired *t*-test according to homogeneity test for variance to compare measurement data and *Fisher\'s*exact test to compare enumeration data, was performed to assess statistically significant variables, and those with *p*\<0.10 were then entered into a logistic regression analysis to identify the independent risk factors for postoperative pulmonary complications. The regression coefficients of factors with *p*\<0.05 were calculated. The*Hosmer-Lemeshow* goodness of fit coefficient was computed for the regression model. The stepwise multivariate logistic regression was also performed to assess the influence of postoperative pulmonary complications as an independent risk factor on hospital death.

Results
=======

From January 2005 to December 2012, 2056 consecutive adult patients (585 females, with a mean age of 46.3 ± 4.3 years old of age) undergoing cardiac surgery with CPB were investigated and retrospectively analyzed. Among them, 143 patients, accounting for 6.96% of the total population, suffered from postoperative pulmonary complications (112 patients suffering from postoperative pneumonia, 64 patients suffering from postoperative respiratory failure, and 11 patients undergoing re-intubation) and were included in the PPC group (group of postoperative pulmonary complications), and the remaining patients (1913 patients) did not receive postoperative pneumonia or postoperative respiratory failure or re-intubation and were included in the non-PPC group. The PPC group had significantly longer duration of mechanical ventilation as compared to the non-PPC group (36.4±8.7 hours versus 16.8±3.7 hours, p\<0.0001).

Result of the univariate analysis is shown in Table [1](#T1){ref-type="table"}. It shows that older age, woman, recent smoking, chronic obstructive pulmonary disease, preoperative congestive heart failure, preoperative vasoactive drugs support, preoperative PaO~2~, duration of CPB and ACC, intra-operative phrenic nerve injury, peri-operative use of IABP, postoperative cerebral vascular accident, postoperative new onset of atrial fibrillation, postoperative acute kidney injury and postoperative anaemia were relative risk factors for postoperative pulmonary complications.

Those variables with *p*\<0.10 obtained through the univariate analysis were then entered into multivariate logistic regression analysis (PPC or not as independent variable, variables with *p*\<0.10 obtained through univariate analysis as dependent variables). As shown in Table [2](#T2){ref-type="table"}, independent risk factors for postoperative pulmonary complications included older age (\>65 years) (OR=3.31, 95%CI 1.71-7.13), preoperative congestive heart failure (OR=2.95, 95%CI 1.41-5.84), preoperative PaO~2~ (OR=0.67, 95%CI 0.33-0.85), duration of CPB (OR=3.15, 95%CI 1.55-6.21), intra-operative phrenic nerve injury (OR=4.59, 95%CI 2.52-9.24), and postoperative acute kidney injury (OR=3.21, 95%CI 1.91-6.67). The *Hosmer-Lemeshow* goodness of fit coefficient of this model was 0.90.

In addition, 72 adult patients died within 30 days of cardiac surgery, with a hospital mortality of 3.5%. The causes of death were as follows: low cardiac output (n=36), sepsis (n=24), malignant arrhythmia (n=6), and gastrointestinal bleeding (n=6). In logistic regression analysis, postoperative pulmonary complication was not a risk factor for hospital death (OR=2.10, 95%CI 0.89-4.33).

Discussions
===========

Pulmonary complications following cardiac surgery with cardiopulmonary bypass are common complications. Postoperative pulmonary complications manifest early as arterial hypoxemia, during the later course as pneumonia, and in rare cases also as acute lung injury. The incidence of postoperative pulmonary complications ranged from 3-16 percent following coronary artery bypass grafting and 5-7 percent following cardiac valvular surgery [@B2]-[@B5], [@B7], [@B9]. In this study, 143 adult patients suffered from postoperative pulmonary complications, accounting for 6.96% of the total population. This result was consistent with previous reports [@B2]-[@B5], [@B7].

It is reported that older age, smoking, obesity, diabetes, chronic obstructive pulmonary disease, hypercapnia, hypoproteinemia, prolonged duration of CPB, postoperative bacteremia, postoperative endocarditis, postoperative gastrointestinal hemorrhage with or without perforation, postoperative acute kidney injury, sternal infection, postoperative cerebral vascular accident and reoperation for bleeding increased the incidence of postoperative pulmonary complications [@B16], [@B17]. This study revealed that independent risk factors for postoperative pulmonary complications included older age (\>65 years), preoperative congestive heart failure, low preoperative PaO~2~, prolonged cardiopulmonary bypass, intra-operative phrenic nerve injury, and postoperative acute kidney injury.

Older age was one of the major risk factors contributing to postoperative pulmonary complications. Patients aged more than 65 years undergoing cardiac surgery with CPB often had multiple concurrent diseases with poor cardiopulmonary reserve. They had a further reduction in their cardiopulmonary performance after cardiac surgery, and were more prone to postoperative low cardiac output and requiring longer ventilation support, and then were more prone to postoperative pulmonary complications.

Preoperative congestive heart failure was an important risk factor for postoperative pulmonary complications. Patients with preoperative congestive heart failure often had left atrial hypertension and pulmonary interstitial edema, which in turn resulted in a change in the pulmonary ventilation/blood flow ratio, thus causing postoperative hypoxemia and prolonged ventilation support [@B18], [@B19]. Preoperative congestive heart failure caused the lymph back to obstacle, pulmonary alveolar edema occurred then, which in turn could have resulted in a change in the pulmonary compliance, thus further aggravating respiratory dysfunction. Therefore, patients with preoperative congestive heart failure were prone to postoperative pulmonary complications. Accordingly, proper preoperative management of congestive heart failure in patients undergoing scheduled cardiac surgery with CPB might contribute to reduce the incidence of postoperative pulmonary complications.

Low preoperative PaO~2~often suggested poor cardiopulmonary function or severe chronic obstructive pulmonary disease in patients. After cardiac surgery with CPB, further reduction in cardiopulmonary function was expected in patients with low preoperative PaO~2~ who consequently were more prone to low cardiac output and requiring longer ventilation support, and thus were more prone to postoperative pulmonary complications. Therefore, proper peri-operative management of cardiopulmonary dysfunction might contribute to improve cardiopulmonary function and shorten postoperative ventilation support, and then reduce the incidence of postoperative pulmonary complications.

Prolonged cardiopulmonary bypass was also a major risk factor for postoperative pulmonary complications. Cardiopulmonary bypass is associated with a systemic inflammatory response, the production of oxygenderived free radicals, the activation of polymorphonuclear neutrophils, and the complement cascade and release of vessel constringent factors [@B20], [@B21]. All these have negative influences on important organs, such as the heart, lung, brain, and kidney. Prolonged cardiopulmonary bypass was expected to negatively influence cardiopulmonary and renal functions, and thus requirement of longer ventilation support and increase of postoperative pulmonary complications. In addition, prolonged cardiopulmonary bypass associated with complex disease, complicated operation, and imperfect myocardial protection may cause postoperative pulmonary complications. Thus, further refinement of surgical techniques and decrease in duration of cardiopulmonary bypass may contribute to reduction of postoperative pulmonary complications.

Phrenic nerve injury following cardiac surgery was variable in its incidence depending on the diligence with which it was sought. Definitive studies have shown this complication to be related to cold-induced injury during myocardial protection strategies and possibly to mechanical injury during internal mammary artery harvesting [@B22]. Right phrenic nerve injury, although rarely life-threatening, was more prone to lead to diaphragmatic paralysis, lung atelectasis, severe pulmonary dysfunction requiring prolonged mechanical ventilation or re-intubation, and other associated morbidities and even mortality. Right phrenic nerve injury was an independent risk factor for postoperative respiratory complications [@B22]. Although rare, bilateral phrenic nerve injury may lead to postoperative pulmonary complications [@B23].

Postoperative acute kidney injury, a common complication after cardiac surgery, remained an important adverse event and has been shown to be associated with postoperative complications, longer hospital stay, higher cost and increased mortality. Severe acute kidney injury, which usually combined with multiple organ dysfunction syndrome, low cardiac output, endotoxemia, hypervolemia, hyperkalemia and acidosis, requiring renal replacement therapy, had negative impact on respiratory function, causing prolonged ventilation support or re-intubation, and then, increasing the incidence of postoperative pulmonary complications [@B24].

Generally speaking, postoperative pulmonary complications led to increased mortality. In this study, postoperative pulmonary complication was not a risk factor for hospital death through multivariate logistic regression analysis. But further large multicenter studies are required.

The primary limitation of this study was its retrospective and observational nature, limiting generalization of its results. Another limitation of this study was the lack of detailed respiratory function data. PaO~2~ was measured preoperatively, but forced expiratory volume in 1 second (FEV~1~) and forced vital capacity (FVC) were not routinely measured before cardiac surgery in the department of cardiovascular surgery of Tongji Hospital of Tongji University.

In conclusion, older age, preoperative congestive heart failure, low preoperative PaO~2~, prolonged cardiopulmonary bypass, intra-operative phrenic nerve injury, and postoperative acute kidney injury were six independent risk factors for pulmonary complications following cardiac surgery with cardiopulmonary bypass. Pulmonary complications following cardiac surgery with cardiopulmonary bypass may be reduced by shortening duration of cardiopulmonary bypass and avoiding intra-operative phrenic nerve injury. The proper peri-operative management of cardiopulmonary dysfunction may contribute towards reducing pulmonary complications following cardiac surgery with cardiopulmonary bypass and facilitate recovery.

###### 

Comparison of clinical data between the two groups.

  ---------------------------------------------------------------------------------------------------------------------
  Factors                                     PPC\                                 Non-PPC\     p value      
                                              (n=143)                              (n=1913)                  
  ------------------------------------------- ------------------------------------ ------------ ------------ ----------
  **Pre-operation**                                                                                          

                                              Older age (over 65 years old)        50(34.9%)    215(11.2%)   \<0.0001

                                              Woman                                55(38.5%)    530(27.7%)   0.0071

                                              BMI (kg/m^2^)                        25.2±3.2     24.9±2.5     0.1757

                                              Recent smoking                       57(39.9%)    545(28.5%)   0.0055

                                              Diabetes mellitus                    20(13.9%)    211(11.0%)   0.2729

                                              Hypertension                         43(30.1%)    612(31.9%)   0.7099

                                              Hypercholesterolemia                 28(19.6%)    405(21.2%)   0.7498

                                              COPD                                 46(32.2%)    114(5.9%)    \<0.0001

                                              Cerebrovascular disease              18(12.6%)    161(8.4%)    0.0912

                                              Long-term use of steroid hormone     2(1.4%)      6(0.3%)      0.1020

                                              Chronic renal dysfunction            7(4.9%)      55(2.9%)     0.1968

                                              Recent MI                            20(13.9%)    186(9.7%)    0.1113

                                              Prior heart operation                4(2.8%)      21(1.1%)     0.0907

                                              Congestive heart failure             52(36.4%)    223(11.7%)   0.0008

                                              Hemoglobin level (mg/dl)             11.0±2.2     11.2±2.0     0.2523

                                              Impaired left ventricular function   12(8.4%)     102(5.3%)    0.1285

                                              Vasoactive drugs support             22 (15.4%)   164 (8.6%)   0.0097

                                              Atrial fibrillation                  49(34.3%)    512(26.8%)   0.0639

                                              LVEDD (mm)                           52.9±7.6     52.3±4.2     0.1257

                                              PaO~2~ (mmHg)                        74.8±8.3     77.8±5.8     \<0.0001

  **Intra-operation**                                                                                        

                                              Emergency surgery                    5(3.5%)      38(2.0%)     0.2186

                                              Type of operation                                              0.0732

                                              Valve only                           65(45.4%)    706(36.9%)   

                                              CABG only                            28(19.6%)    305(15.9%)   

                                              Valve+CABG                           11(7.7%)     73(3.8%)     

                                              Aortic surgery                       29(20.3%)    61(3.2%)     

                                              CHD                                  10(7.0%)     768(40.2%)   

                                              CPB (min)                            95.8±15.5    92.5±12.6    0.0030

                                              ACC (min)                            78.6±8.8     76.3±7.8     0.0008

  **Post-operation**(before extubation**)**                                                                  

                                              Use of IABP                          13(9.1%)     72(3.8%)     0.0067

                                              AMI                                  2(1.4%)      6(0.3%)      0.1020

                                              New onset of atrial fibrillation     39(27.3%)    317(16.6%)   0.0019

                                              Pleural effusion                     21(14.7%)    195(10.2%)   0.1179

                                              Acute kidney injury                  35(24.5%)    187(9.8%)    \<0.0001

                                              Cerebral vascular accident           12 (8.4%)    81(4.2%)     0.0334

                                              Sternal infection                    8(5.6%)      62(3.2%)     0.1464

                                              Re-operation for bleeding            5(3.5%)      30(1.6%)     0.0911

                                              Anaemia                              46(32.2%)    437(22.8%)   0.0139

                                              Phrenic nerve injury                 29(20.3%)    95(5.0%)     \<0.0001
  ---------------------------------------------------------------------------------------------------------------------

PPC: postoperative pulmonary complications; BMI: body mass index; COPD: chronic obstructive pulmonary disease; MI: myocardial infarction; LVEDD: left ventricular end-diastolic diameter; PaO~2~: arterial oxygenation; CABG, coronary artery bypass grafting; CHD, congenital heart disease; CPB: cardiopulmonary bypass; ACC: aortic cross clamping; IABP, intra-aortic balloon pump; AMI: acute myocardial infarction.

###### 

Independent risk factors for PPC.

  Factors                                 OR     95%CI       p value
  --------------------------------------- ------ ----------- ---------
  Older age (over 65 years old of age)    3.31   1.71-7.13   0.0035
  Preoperative congestive heart failure   2.95   1.41-5.84   0.0131
  Preoperative PaO~2~                     0.67   0.33-0.85   0.0245
  Duration of cardiopulmonary bypass      3.15   1.55-6.21   0.0171
  Intra-operative phrenic nerve injury    4.59   2.52-9.24   0.0046
  Postoperative acute kidney injury       3.21   1.91-6.67   0.0072

The *Hosmer-Lemeshow* goodness of fit coefficient of this model was 0.90. PPC, postoperative pulmonary complications; OR: odds ratio; CI: confidence interval; PaO~2~: arterial oxygenation.
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